Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (51-60 of 607) with videos related to

Pageof 61
Sort By:
Rheumatic Diseases Clinics of North America|March 11, 2008
Current approaches to the management of early active diffuse scleroderma skin diseaseSvetlana I Nihtyanova, Christopher P Denton
Journal of Scleroderma and Related Disorders|April 6, 2022
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertensionJ G Coghlan, Christopher P Denton
Current Opinion in Rheumatology|March 2, 2010
Innovative therapies for systemic sclerosisVoon H Ong, Christopher P Denton
Nature Reviews. Rheumatology|February 4, 2010
Autoantibodies as predictive tools in systemic sclerosisSvetlana I Nihtyanova, Christopher P Denton
Nature Reviews. Rheumatology|October 1, 2014
Interstitial lung disease in connective tissue disease--mechanisms and managementAthol U Wells, Christopher P Denton
Journal of Scleroderma and Related Disorders|April 6, 2022
Pathogenesis of systemic sclerosis associated interstitial lung diseaseSvetlana I Nihtyanova, Christopher P Denton
Current Opinion in Rheumatology|September 4, 2009
Disease-modifying treatment in systemic sclerosis: current statusNiamh P Quillinan, Christopher P Denton
Rheumatic Diseases Clinics of North America|July 5, 2003
Pulmonary hypertension in systemic sclerosisChristopher P Denton, Carol M Black
Springer Seminars in Immunopathology|July 18, 2001
Combination therapies for systemic sclerosisC P Denton, C M Black
British Journal of Rheumatology|January 1, 1995
The management of systemic sclerosisC M Black, C P Denton
Pageof 61

Showing results (51-60 of 607) with videos related to

Sort By:
Pageof 61
Rheumatic Diseases Clinics of North America|March 11, 2008
Current approaches to the management of early active diffuse scleroderma skin diseaseSvetlana I Nihtyanova, Christopher P Denton
Journal of Scleroderma and Related Disorders|April 6, 2022
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertensionJ G Coghlan, Christopher P Denton
Current Opinion in Rheumatology|March 2, 2010
Innovative therapies for systemic sclerosisVoon H Ong, Christopher P Denton
Nature Reviews. Rheumatology|February 4, 2010
Autoantibodies as predictive tools in systemic sclerosisSvetlana I Nihtyanova, Christopher P Denton
Nature Reviews. Rheumatology|October 1, 2014
Interstitial lung disease in connective tissue disease--mechanisms and managementAthol U Wells, Christopher P Denton
Journal of Scleroderma and Related Disorders|April 6, 2022
Pathogenesis of systemic sclerosis associated interstitial lung diseaseSvetlana I Nihtyanova, Christopher P Denton
Current Opinion in Rheumatology|September 4, 2009
Disease-modifying treatment in systemic sclerosis: current statusNiamh P Quillinan, Christopher P Denton
Rheumatic Diseases Clinics of North America|July 5, 2003
Pulmonary hypertension in systemic sclerosisChristopher P Denton, Carol M Black
Springer Seminars in Immunopathology|July 18, 2001
Combination therapies for systemic sclerosisC P Denton, C M Black
British Journal of Rheumatology|January 1, 1995
The management of systemic sclerosisC M Black, C P Denton
Pageof 61